Gingrich Jon S. 4
4 · AxoGen, Inc. · Filed Dec 20, 2017
Insider Transaction Report
Form 4
AxoGen, Inc.AXGN
Gingrich Jon S.
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to purchase)
2017-12-18+32,600→ 32,600 totalExercise: $27.00Exp: 2027-12-18→ Common Stock (32,600 underlying) - Award
Restricted Stock Units
2017-12-18+5,500→ 5,500 total→ Common Stock (5,500 underlying)
Footnotes (3)
- [F1]All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on December 18, 2021 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock.
- [F3]All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.